Halog

   
Google
 
Web NewDrugInformation.com

Halog


Drug - Halog
The trade name of the product as shown on the labeling.

Dosage - OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Halcinonide
Multiple ingredients are in alphabetical order.

Strength - 0.025%
The potency of the active ingredient(s), Halcinonide. May repeat for multiple part products.

Applicant - BRISTOL MYERS SQUIBB
The firm name holding legal responsibility for Halog. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018125
The FDA assigned number to Halog. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Halog. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Halog was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Halog. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Halog is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bristol Myers Squibb
The full name of the firm holding legal responsibility for the new application of Halog.

Halog